Solutions for Radiochemicals

We are pleased to offer a broad selection of PET and SPECT precursors, reference standards, reagent kits and consumables. Our products have been developed for the production of 18F ,11C , 68Ga , 177Lu tracers, with the mainstream synthesis modules

Explore more

Products and Services

Stable Isotopes

Our Oxygen-18 water is manufactured according to cGMP standards.We offer different forms of O-18 with a variety of packaging options, as well as one-time and long-term delivery contracts.

Total Solutions

We offer ready-to-use reagent kits and ancillary kits for you routine production or research production of radioactive tracers, the ancillaries including cartridges, cassettes, filters, and syringes.

Sterile Vials

Fully integrated ready-to-use solutions for your aseptic manufacturing. A selection of vials with all USP type I glass, with volumes ranging from 2ml to 250ml, is available.

Biochemicals

We supply the precursors for normal GMP production, as well as some research compounds for new tracers. HIC provides custom synthesis services to academic and government institutions under strict confidence.

CMO Service

HIC is also a highly-experienced cGMP Contract Manufacturing Organization (CMO) specializing in APIs, reagents, cassettes and sterile fillings.

Others

We provides an extensive line of tungsten and lead radiation shielding products such as dispensing pigs, vial adapters, syringe and vial shields etc.
history
0+

Years of Experience

developer_mode
0+

RTU Kits Developed

support_agent
0+

Global Clients

people_alt
0+

Employees

News

Huayi Isotopes Achieves FDA DMF Acceptance for DOTATATE ACETATE

Huayi Isotopes Achieves FDA DMF Acceptance for DOTATATE ACETATE

Huayi Isotopes, a subsidiary of Huayi Technology Co., Ltd., has received a Drug Master File (DMF) acceptance letter from the U.S. Food and Drug Administration (FDA) for its DOTATATE ACETATE (DMF No. 041558), a peptide-based precursor for radiopharmaceuticals.

More
Huayi Pharmaceutical (Guangdong) Co., Ltd. Obtains Radioactive Pharmaceutical Production License

Huayi Pharmaceutical (Guangdong) Co., Ltd. Obtains Radioactive Pharmaceutical Production License

Huayi Pharmaceutical (Guangdong) Co., Ltd. successfully obtained the “Radioactive Pharmaceutical Production License” issued by the National Medical Products Administration.

More
HIC at 2025 ALASBIMN: Exploring Frontiers in Nuclear Medicine & Molecular Imaging

HIC at 2025 ALASBIMN: Exploring Frontiers in Nuclear Medicine & Molecular Imaging

More
Huayi Highlights Full Industrial Chain Expertise at EANM 2024 : Advancing Nuclear Medicine Together

Huayi Highlights Full Industrial Chain Expertise at EANM 2024 : Advancing Nuclear Medicine Together

More
Huayi Celebrates Milestone Achievement with DMF Registration for PSMA-11 Precursor

Huayi Celebrates Milestone Achievement with DMF Registration for PSMA-11 Precursor

We proudly announces a significant milestone with the successful acquisition of Drug Master File (DMF) registration for the PSMA-11 precursor. This achievement underscores Huayi's unwavering commitment to upholding the highest standards in the development and production of radiopharmaceuticals.

More
Cookies

We use cookies to understand how you use our site, to personalize content and to improve your experience. By continuing to use our site, you accept our use of cookies and revised. Privacy Policy

Accept cookies